Raptor Pharma (RPTP) Tops Q3 EPS by 4c

Raptor Pharma (NASDAQ: RPTP) reported Q3 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $25.8 million versus the consensus estimate of $24.25 million.

For earnings history and earnings-related data on Raptor Pharma (RPTP) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22